Development and Scale-up of a Route to ATR Inhibitor AZD6738 - Goundry, W R. F; Dai, K; Gonzalez, M; Legg, D; O’Kearney-McMullan, A; Morrison, J; Stark, A; Siedlecki, P; Tomlin, P; Yang, J (Org. Process Res. Dev., 2019)
AstraZeneca, Macclesfield, UK; Changzhou SynTheAll Pharmaceutical Co., Ltd., Changzhou and Asymchem Laboratories Co. Ltd., Tianjin, P. R. of China